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Abstract
Background: Platelet adhesion and subsequent thrombus formation on a subendothelial matrix
at the site of vascular damage play a crucial role in the arrest of posttraumatic bleeding but also in
different pathological thrombotic events, such as acute coronary syndrome and stroke. Recently
published studies have clearly demonstrated that platelet integri αIIbβ3 is intimately involved in the
occlusive thrombus formation at the site of endothelial damage. Therefore, any genetic variation in
the expression of this receptor may lead to an excessive bleeding or excessive thrombus formation.
In this study, we evaluated the influence of HPA-1 polymorphism of integrin αIIbβ3 on platelet
adhesion onto immobilized fibrinogen using an in vitro system simulating blood flow.
Methods: Platelets in anticoagulated whole blood [49 healthy previously genotyped blood donors)
were labelled with fluorescence dye and perfused through a rectangular flow chamber (shear rates
of 50 s-1, 500 s-1 and 1500 s-1). A fluorescence laser-scan microscope was used for visualisation and
quantification of platelet adhesion at 15 sec, 1 and 5 minutes after start of perfusion.
Results: During perfusion, the platelet adhesion linearly increased with regard to exposition time
and shear rate. Perfusion of blood preincubated with Abciximab over fibrinogen-coated cover-slips
showed reduced platelet adherence (absolute fluorescence: 168 ± 35 U vs. 53000 ± 19000 at
control experiments, p < 0.05), as well as by perfusion over BSA-coated glass coverslips. Platelet
with HPA-1a/1a genotype exhibited initial better adhesion but they also exhibited higher
detachment under arterial flow conditions compared to the HPA-1b/1b platelets. Analysis of stable
adhesion rate indicate that the platelets carrying the HPA-1b/1b genotype have a higher reactivity
threshold for initial interaction with fibrinogen but under the higher shear rate (in regard to time
of perfusion) also realize more stable bonds with fibrinogen than platelets with the HPA-1a/1a
genotype.
Conclusion: Our data support the contention that genetically determined variants of platelet
integrins αIIbβ3 could play a role in arterial thrombogenesis and thus confirm the hypothesis
derived from epidemiological studies.
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Background
A platelet-dependent process is the underlying mecha-
nism of arterial thrombosis, and the critical role of plate-
lets in this process is now widely accepted [1,2].
Participation of platelets in arterial thrombosis is centered
on the platelet's adhesive properties and the ability to
respond to stimuli with rapid activation and, in turn,
aggregation [2] – the same features that support the arrest
of bleeding from wounds. The normal function of plate-
lets is, however, to arrest bleeding from wounds, which
requires adhesion to altered vascular surfaces and rapid
cellular activation ensuring the accumulation of circulat-
ing platelets and the formation of fibrin in the growing
thrombus [1-4].
There are two critical points in thrombus formation: 1)
adhesion of inactivated (resting) platelets to subendothe-
lial components such as collagen, deposed vWF or fibrin-
ogen and 2) spreading of activated platelets with
consecutive aggregation and thrombus formation. Both
processes involve the platelet integrin receptors αIIbβ3.
The integrin αIIbβ3 is the most abundant receptor on the
platelet membrane surface, at about 80,000 copies per
platelet, and is known as the receptor for fibrinogen or
von Willebrand factor that mediates platelet adhesion,
i.e., the formation of platelet aggregates [5-7]. This recep-
tor is also characterized by several inheritable dimor-
phisms. The two most common and clinically important
β3 alleles encode Leu33 (PlA1 or HPA-1a) and Pro33
(PlA2 or HPA-1b allele of the subunit β3 of the integrin
αIIbβ3), with gene frequencies of 0.85 and 0.15, respec-
tively, in the Caucasian population. Clinical studies con-
ducted within the last ten years indicate that there could
be a genetically determined predisposition for hyperag-
gregability which might be mediated by polymorphic
receptors including integrin αIIbβ3 involved in platelet
adhesion and aggregation [8-14].
Since Weiss et al. [8] for first time in 1996 reported that
the gene frequency of the HPA-1b allele of integrin αIIbβ3
was significantly higher among young patients with myo-
cardial infarction compared with age-matched controls,
numerous clinical studies were conducted in order to
define a role of related polymorphisms in arterial throm-
bosis. Surprisingly, these studies gave different, and in
some cases, contradictory results [8,9,14-16].
Taking into consideration the controversy surrounding
these clinical correlations, the goal of this study is to test
the functional relevance of HPA-1 platelet receptor poly-
morphism under standardized microenvironmental con-
ditions using a well-characterized in-vitro flow model.
Methods and subjects
Subjects
The study was conducted on 49 healthy blood donors
who were previously genotyped. The mean age was 42 ±
12 years, 35 (72%) were men and 14 (28%) were women.
None of donors had taken any medication in the preced-
ing 14 days. Screening parameters of hemostasis as well as
factors of coagulation were within the normal range
according to the international standards. Women on hor-
mone replacement therapy and hormonal contraception,
excessive smokers, obese subjects and individuals with
positive familiar history related to arterial or venous dis-
ease were excluded. Since the frequency distribution of
platelet glycoprotein alleles differs with regard to race,
only Caucasians were included in the study. This study
was performed according to the Helsinki declaration and
was approved by the local ethical committee.
Blood preparation
Venous blood obtained from the cubital vein was imme-
diately anticoagulated with the thrombin inhibitor
PPACK (D-phenylalanyl-L-prolyl-L-arginine chlorome-
thyl ketone dihidrochloride, final concentration 40 µM,
Calbiochem, San Diego Ca, USA). Platelets were labelled
with a fluorescence dye mepacrine (quinacrine dihydro-
chloride, final concentration10 µM; Sigma Chemical, 60
min at 22°C). It immediately accumulates in the delta
granules of platelets but does not influence platelet phys-
iology [17]. Blood was used within two hours of with-
drawal. Blood anticoagulated with EDTA and 3.4%
sodium citrate was immediately processed for genotyping
and for assessment of screening parameters and factors of
coagulation, respectively.
Determination of HPA-1 polymorphism of the β subunit of 
αIIbβ3
EDTA-anticoagulated blood was immediately centrifuged
at 2500 rpm for 10 min at 4°C. Cells were further proc-
essed to assess genetic polymorphisms. Genomic DNA
was extracted from whole blood with the QIAmp blood
kit (Qiagen, Hilden, Germany). After amplification by
polymerase chain reaction, genotypes were determined by
allele-specific restriction enzyme analysis. Determination
of the HPA-1 polymorphism of the β subunit of was per-
formed as previously described [18].
Preparation of fibrinogen coated cover slips
Glass cover slips (24 × 50 mm) coated with 50 µl of fibrin-
ogen solution (2,5 mg/ml, Sigma-Aldrich) that a sharp
interface of the adhesion molecule was formed 10 mm
away from the smaller edge of the cover slip [19]. The
cover slip was placed in a humid environment (60 min at
37°C) to allow the protein to adhere to the glass surface.
Coated cover slips were rinsed with 10 ml of 50 mmol/l
phosphate buffered saline (pH 7.35, Serag-Wiessner, Ger-Thrombosis Journal 2007, 5:2 http://www.thrombosisjournal.com/content/5/1/2
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many) to remove the non-adherent fibrinogen and placed
in the flow chamber. Fibrinogen density on the glass sur-
faces was calculated to be 0.13 µg/mm2. For the control
experiments cover slips were coated with bovine serum
albumin in final concentration of 5 µg/mm2. A specificity
of binding of platelets to immobilized fibrinogen was
tested in experiments (n = 3) with blood preincubated
with Abciximab (c7E3, Centocor, Inc; 4 µg/mL, 10 min).
c7E3 Fab is a chimerical human/mouse Fab fragment
derived from the murine monoclonal 7E3 antibody that
binds selectively to the platelet integrin αIIbβ3.
Flow chamber, perfusion, laser-scan microscopy and data 
acquisition
Platelets adhesion rates onto fibrinogen and collagen-
coated glass coverslips were measured in the rectangular
flow chamber under linear shear rate of 50 s-1, 500 s-1 and
1500 s-1. A shear rate of 50 s-1 represents a venose system,
500 s-1 mimics a wall shear rate of larger arteries and 1500
s-1 represents a typical arteriolar shear rate as well as a
shear rate by moderate arterial stenosis [2,4].
A laser-scan microscope (Axiovert 100 M, Carl-Zeiss, Jena,
Germany) allowed real-time visualisation of labelled
platelets during perfusion through the chamber. To assess
time-course of platelet adhesion a series of images (five
images per series, 0,7 s pro image) were made at 15 sec, 1
and 5 minutes. Image analysis was performed using the
ImageJ software (version 1.26t, NIH, USA). This program
allows evaluation of platelet-surface interaction, consecu-
tive aggregation and evaluation of thrombus generation
within the defined area of each image. A single frame
image corresponded to the area of 980 × 980 µm. The
blood was perfused over fibrinogen-coated cover slips as
described above. The number of stable, attached platelets
on the surface was calculated as number of platelets,
which remain their initial adhering position in the first
and second image (time frame of 0.7 sec). Platelets were
considered to move on the surface when exhibiting a spa-
tial displacement greater than one platelet diameter. To
estimate motion, a series of 5 images (time frame 0.7 sec)
at one time point were made. Using ImageJ software
images were binarised and a threshold was applied to dis-
tinguish platelet from background. The first two consecu-
tive frames in a series were superimposed using the logical
AND function and the resulting image represented only
the overlapping areas of single platelet at two different
times.
Calculations and statistics
Data in text are given as mean values ± SD. The absolute
fluorescence was expressed as arbitrary units (pixel units,
AU) and represents sum of fluorescence of each thrombus
or individual adherent platelet in one defined area. The
platelet adhesion was calculated using a logic function of
the applied software (ImageJ) and represented a stable
platelet adhesion between the first and second image.
Taking into consideration that initial platelet adhesion
and platelet detachment after initial adhesion is a
dynamic process, dependent from shear rate and per-
fusion time data were normalized. Absolute fluorescence
recorded after five minute of perfusion was divided by
recorded fluorescence after 1 minute or after 15 sec of per-
fusion and expressed as a relative adhesion. The relative
adhesion represents the increase of absolute fluorescence
in function of time and reflects number of stable adherent
platelet. Data normalisation allow us to evaluate stability
of adherent platelets and to quantify increase of stable
platelet adhesion onto immobilized fibrinogen under dif-
ferent shear rates in function of time.
Differences between experimental groups were tested
using Student's t-test (two-sided). Regression analyses
were based on individual measurements using Spear-
man's rank correlation coefficient. Statistical analyses
were performed using SPSS for Windows, version 6.0.1. P-
value of less than 0.05 (two-sided) was used to indicate a
significant difference.
Results
Clinical chemistry, haematology and haemostatic labora-
tory values in the blood obtained from 49 healthy blood
donors were within the normal ranges. The mean age was
42 ± 12 years and did not significantly differ between
male and female (41 ± 10 vs. 46 ± 12 years, p > 0.05),
respectively.
During the perfusion through the rectangular chamber,
the platelet adhesion linearly increased with regard to the
exposition time at each tested shear rate. In 49 individual
experiments, mean platelet adhesion onto fibrinogen-
coated coverslips at a shear rate of 50 s-1, increased from
15 sec to 5 minutes 3.47 fold (from 3006 ± 1936 AU to
10449 ± 4850 AU), at 500 s-1 9.54-fold (from 4074 ± 1986
AU to 38900 ± 13290 AU) and at 1500 s-1 platelet adhe-
sion increased 14.5 fold (from 3660 AU ± 1917 U to
54500 U ± 22400 AU), respectively.
A specificity of binding of platelets to immobilized fibrin-
ogen was tested bi-directionally with two additional
experimental designs. In three experiments a blood was
additionally incubated with Abciximab (4 µg/ml for 10
min), c7E3 fragment, which showed a high affinity to the
platelet integrin αIIbβ3. A perfusion (1500 s-1) of the pre-
incubated blood over fibrinogen-coated cover slips omits
to show significant platelet adherence (absolute fluores-
cence of stable adherent platelet: 168 U ± 35 U vs. 53000
U ± 19000 U at control experiments, p < 0.05). Similarly,
in experiments with perfusion of labelled platelets in
whole blood over BSA coated glass cover slips no signifi-Thrombosis Journal 2007, 5:2 http://www.thrombosisjournal.com/content/5/1/2
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cant adherence was found. The relationship between
platelet adhesion and concentration of soluble plasma
fibrinogen was not found (p > 0.05). Additional experi-
ments, conducted with supplementation of soluble fibrin-
ogen (up to 9 g/L), omitted to show any difference with
regard to the untreated blood (data not present).
To test the influence of the HPA-1 polymorphism of
integrin  αIIbβ3 on platelet adhesion during perfusion
over fibrinogen-coated coverslips blood obtained from 49
blood donors of known HPA-1 genotype (25 with HPA-
1a/1a, 12 with HPA-1a1b and 12 with HPA-1b1b geno-
type) was used in flow experiments.
Platelet adhesion onto immobilized fibrinogen under
venous and arterial flow (50 s-1–1500 s-1) was analyzed
after 15 sec, 1 min, and 5 min of perfusion and expressed
as absolute fluorescence in arbitrary units (AU). Figures
1A and 1B show platelet adhesion onto immobilized
fibrinogen.
Surprisingly, platelets with HPA-1a/1a and HPA-1a/1b
genotypes showed higher adhesion activity compared to
platelets with the HPA-1b/1b genotype. The significantly
higher adhesion activity of platelets with the HPA-1a/1a
genotype was observed after 1 min of perfusion at 50 s-1
and at 1500 s-1, respectively (p < 0.05, Table 1). A similar
trend was also observed at 500 s-1 but without statistical
significance.
After 5 min of perfusion, a significant difference between
platelet adhesion activities with regard to the HPA-1 pol-
ymorphism was found only under venous flow (50 s-1)
between HPA-1a/1b and HPA-1b/1b genotypes (14224 ±
4718 AU vs. 8436 ± 4660 AU, p < 0.05). Even higher
platelet adhesion activity of HPA-1a/1a and HPA-1a/1b
genotype compared to HPA-1b/1b genotype was also
observed under arterial flow, no significant difference was
observed neither at 500 s-1 nor at 1500 s-1, (p > 0.05, Table
1).
As shown, platelets with HPA-1b/1b genotype after 1 and
5 min of perfusion under arterial flow conditions reached
64% and 86% of the adhesion activity of platelets with the
HPA-1a/1a genotype. This dynamic change could indicate
that the platelets carrying the HPA-1b/1b genotype have a
higher reactivity threshold for initial interaction fibrino-
gen but also under the higher shear rate (in regard to time
of perfusion) also realize more stable bonds with fibrino-
gen than platelets with the HPA-1a/1a genotype.
To test in which order the HPA-1 polymorphism modu-
lated stability of platelet adhesion onto immobilized
fibrinogen the data were "normalized" (see Methods),
Platelet adhesion onto immobilized fibrinogen under different shear rate conditions with regard to the HPA-1 polymorphism (n  = 49) Figure 1
Platelet adhesion onto immobilized fibrinogen under different shear rate conditions with regard to the HPA-1 polymorphism (n 
= 49). Per each subject 3 flow experiments were conducted (50 s-1, 500 s-1 and 1500 s-1). At each time point of perfusion (1 
min and 5 min) a stack of 5 images was collected and analyzed. Finally 147 perfusion experiments were conducted and 1470 
images were analyzed. Each bar represents mean value ± SE.Thrombosis Journal 2007, 5:2 http://www.thrombosisjournal.com/content/5/1/2
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and a time course of stable platelet adhesion was analyzed
with regard to the shear rate and HPA-1 polymorphism.
According to the normalized data, an adhesion rate (adhe-
sion between 15 sec and 5 min of perfusion) of platelets
with HPA-1b/1b genotype was significantly higher in rela-
tion to HPA-1a/1a genotype (Fig. 2). A relative adhesion
at shear rate of 1500 s-1 was 23.17 ± 9.9 for 1b/1b geno-
type versus 14.8 ± 6.5 for 1a/1a genotype, p < 0.05, respec-
tively. A marginal statistical significance was also observed
at shear rate of 500 s-1 (HPA-1b/1b 14.45 ± 6.4 vs. 10.66
± 5.0 for HPA-1a/1a, p = 0.07).
The time course of platelet adhesion onto immobilized
fibrinogen, in regard to the shear rate and genotype was
further analyzed. Thrombus growth was analyzed within
two different periods of perfusion, at "initial phase" (Fig.
3A) and at "late phase" (Fig. 3B). The time frame between
start of perfusion (15 sec, point zero) and one min of per-
fusion was designated as initial phase and the time frame
between min 1 and min 5 as late phase. A statistically sig-
nificant difference in platelet adhesion with regard to the
HPA-1 polymorphism was observed. Surprisingly, the
observed difference between different genotype was
already present in the initial phase of platelet adhesion
(Fig. 3A). The relative adhesion at shear stress of 1500 s-1
was 5.62 ± 2.4 for HPA-1b/1b versus 4.32 ± 1.25 for HPA-
1a/1a genotype, p < 0.05, respectively. At 500 s-1, a similar
trend was observed but without statistical significance
(HPA-1b/1b 4.22 ± 2.5 vs. 3.13 ± 1.34 for HPA-1a/1a, p >
0.05). In the late phase (quotient between min 1 and min
5, Fig. 3B), a relative adhesion at shear rate of 1500 s-1 was
4.42 ± 1.21 vs. 3.35 ± 1.17 for 1a/1a genotype, p < 0.05,
respectively. A significance was also observed at venous
shear rate 2.06 ± 1.32 for HPA-1b/1b vs. 1.39 ± 0.32 for
HPA1a/1a, p > 0.05. At 500 s-1, a similar trend was
observed but without statistical significance (HPA-1b/1b
3.72 ± 1.1 vs. 3.29 ± 0.69 for HPA-1a/1a. Between hetero-
zygous (HPA-1a/1b) and homozygous (HPA-1a/1a) gen-
otype, no significant difference in platelet relative
adhesion was observed.
Discussion
In this study, we now provide experimental evidence that
platelet adhesion to immobilized fibrinogen is modu-
lated by platelet receptor polymorphism. This modula-
tion is determined by the specific receptor-ligand
interaction and shear rate. In this sense, we provide exper-
imental support for the epidemiological association of the
related platelet-receptor polymorphism and arterial
thrombosis.
Increase of stable platelet adhesion onto immobilized fibrino- gen under different shear rates (50 s-1, 500 s-1 and 1500 s-1)  with regard to the HPA-1 polymorphism within 5 min (each  bar represents mean value ± SE) Figure 2
Increase of stable platelet adhesion onto immobilized fibrino-
gen under different shear rates (50 s-1, 500 s-1 and 1500 s-1) 
with regard to the HPA-1 polymorphism within 5 min (each 
bar represents mean value ± SE). The relative adhesion rep-
resents the increase of absolute fluorescence in function of 
time (absolute fluorescence recorded after five minute of 
perfusion was divided by recorded fluorescence after 1 
minute or after 15 sec of perfusion).
Table 1: Platelet adhesion (mean ± SD) onto immobilized fibrinogen expressed as absolute fluorescence (AU) related to the platelet 
HPA-1 polymorphism, shear rate and perfusion time.
Shear rate and perfusion time Platelet adhesion, AU
venose shear rate, 50 s-1 HPA-1a/1a HPA-1a/1b HPA-1b/1b
1 min 7402 ± 2542 8910 ± 2896 4947 ± 2699
5 min 10429 ± 4611 14224 ± 4718 8436 ± 4660
arterial shear rate 500 s-1
1 min 11974 ± 2494 14170 ± 5178 10520 ± 9791
5 min 40319 ± 11255 42424 ± 12344 33581 ± 18756
arterial shear rate 1500 s-1
1 min 16324 ± 5515 20474 ± 8547 10384 ± 2516
5 min 53578 ± 19251 64548 ± 32963 46154 ± 17221Thrombosis Journal 2007, 5:2 http://www.thrombosisjournal.com/content/5/1/2
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Blood from 49 subjects was collected for use in flow
experiments, in order to test the influence of β-subunit
polymorphism of integrin αIIbβ3 on platelet adhesion to
immobilized fibrinogen. During perfusion, the shear rate
expresses "dose"-response and time-response characteris-
tics. The adherent platelets formed a single layer on fibrin-
ogen-coated surfaces. A significant linear increase was
observed in platelet adhesion as a function of time, at all
shear rates. Image analysis after 1 and 5 minutes of per-
fusion clearly indicated that the platelets carrying the
HPA-1a allele (HPA-1a/1a and HPA-1a/1b genotypes)
have higher adhesion activity than platelets carrying the
HPA-1b/1b genotype. This difference is continuously
detectable at each shear rate applied and at each time
point (Figure 1A and 1B) but quantitatively dependent on
perfusion time and shear rate. These results are in agree-
ment with the results described by Cadroy et al. [20]. In
their study conducted with non-anticoagulated blood,
blood was drawn directly from volunteers' cubital veins
through a parallel flow chamber. Even though the experi-
mental design differs from ours (shear rates of 650 s-1 and
2600 s-1, perfusion time of 2 and 4 min) one common
result is evident: platelets with the HPA-1a/1a genotype
show higher adhesion activity than platelets with the
HPA1b allele. Carlsson et al. also recently reported similar
results [21]. The results obtained in a static microtitre-
plate system coated with fibrinogen indicated that the
adhesion activity of platelets with the HPA-1b/1b geno-
type is significantly lower compared to the HPA-1a/1a
genotype. Interestingly, Cadroy et al. [20], reported that
enhanced adhesion activity of platelets with the HPA1a
allele observed at 650 s-1 is abolished at shear rates of
2600 s-1. In our experiments, the adhesion activity of
platelets with the HPA1a allele is constantly higher under
venous flow conditions than HPA-1b/1b but varies signif-
icantly in regards to perfusion time in experiments at
shear rates of 1500 s-1. After 1 and 5 min of perfusion
under arterial flow conditions, platelets with HPA-1b/1b
genotype reached 64% and 86% of the adhesion activity
of platelets with the HPA-1a/1a genotype. This observa-
tion has initiated an assumption that platelets carrying the
HPA-1b/1b genotype have a higher reactivity threshold
for initial interaction of αIIbβ3 and fibrinogen but under
the higher shear rate (in regard to time of perfusion) also
realize more stable bonds with fibrinogen than platelets
with the HPA-1a/1a genotype. To test this hypothesis and
to omit some interindividual and methodical variation,
data were "normalized" (see Methods), and a time course
Increase of stable platelet adhesion onto immobilized fibrinogen under different shear rates (50 s-1, 500 s-1 and 1500 s-1) with  regard to the HPA-1 polymorphism within the first 45 seconds of perfusion (Fig. A, "initial phase") and between 1 and 5 min of  perfusion ("late platelet adhesion") Figure 3
Increase of stable platelet adhesion onto immobilized fibrinogen under different shear rates (50 s-1, 500 s-1 and 1500 s-1) with 
regard to the HPA-1 polymorphism within the first 45 seconds of perfusion (Fig. A, "initial phase") and between 1 and 5 min of 
perfusion ("late platelet adhesion"). Each bar represents mean value ± SE. The relative adhesion represents the increase of 
absolute fluorescence in function of time (absolute fluorescence recorded after five minute of perfusion was divided by 
recorded fluorescence after 1 minute or after 15 sec of perfusion).Thrombosis Journal 2007, 5:2 http://www.thrombosisjournal.com/content/5/1/2
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of stable platelet adhesion onto immobilized fibrinogen
was analyzed with regard to the shear rate and HPA-1 pol-
ymorphism.
As shown in the Result, platelets carrying the HPA-1b/1b
genotype demonstrated significantly higher stable adhe-
sion rates between 15 sec and 5 min of perfusion than
platelets carrying the HPA-1a/1a genotype (Fig. 2). Stable
adhesion at a shear rate of 1500 s-1 was 1.64 times higher
compared to the HPA-1a/1a genotype and reached statis-
tical significance. A similar trend was also observed at 500
s-1, (14.45 ± 6.4 vs. 10.66 ± 5.0 for HPA-1b/1b vs. HPA-
1a/1a, respectively, p = 0.07). At a venous shear rate, this
enhanced effect of HPA-1b/1b genotype onto stable plate-
let adhesion was not observed. An analysis of the platelet
adhesion rate of HPA-1b/1b genotype as a function of
time (initial and late phase, see Results) showed that the
observed difference was present both in the initial phase
of the platelet adhesion and in the late phase (Fig. 3A and
Fig. 3B).
Based on this observation, it can be concluded that the
platelets with the HPA-1b/1b genotype develop stronger
adhesive forces than the platelets with the HPA-1a/1a gen-
otype. Statistically significant higher stable adhesion rates
of the 1b/1b genotype could be related to the two deter-
minants: 1) steadier platelet/solid surface interactions and
2) reduced displacement of platelets subjected to the
shear stress. This results in the formation of thrombi that
are more stable than the thrombi formed from HPA-1a/
1a. Cadroy also indicated that clot retraction is enhanced
by the involvement of platelets with the HPA-1b/1b gen-
otype and that thrombi formed from HPA-1b/1b platelets
are more resistant to thrombolysis than the thrombi
formed from HPA-1a/1a platelets [22].
An interesting observation was made in light of the behav-
ior of the heterozygous HPA-1a/1b genotype. According
to our results, (Fig. 1A and 1B and Fig. 3A and 3B), it
appears that platelets carrying "a" and "b" alleles (HPA-
1a/1b) have a functional behavior similar to the HPA-1a/
1a platelets. Absolute and relative adhesion are compara-
ble with platelets that are homozygous for the "a" allele.
Similar to homozygous HPA-1a/1a, our results indicated
that platelets carrying the HPA-1a/1b genotype have a
lower threshold for adhesion onto immobilized fibrino-
gen, but they are not capable of producing a stable platelet
adhesion as compared to platelets with the HPA-1b/1b
genotype. It may be concluded that the functional charac-
teristic of platelets with the HPA-1a/1b genotype is pre-
dominantly determined by the "a" allele. This could
explain the inconsistency of results between some epide-
miological studies in which subjects with different platelet
genotype were pooled (for example: HPA-1a/1a vs. HPA-
1a/1b plus HPA1b/1b).
In experiments conducted under hemodynamic condi-
tions (shear rate ranging from 25 s-1 to 125 s-1) on stabile
cell lines (Chinese hamster ovary cells, CHO) with over
expression of HPA-1a/1a and HPA1b/1b genotypes,
Vijayan et al. [23] also found significant differences in the
cell adhesion onto immobilized fibrinogen in regard to
the β3 polymorphism. By comparing these results with
the results obtained under static conditions [24,25], the
authors concluded that a thrombotic potential of
respected platelet polymorphism could be underesti-
mated when tested under static conditions. The author
provided two indications for a possible explanation for
significant differences in adhesion between the two tested
cells lines. First, using rhodamine-phalloidin-stained
actin, more F-actin was observed at the periphery of the
cells with the HPA-1b/1b genotype compared with the
HPA-1a/1a genotype, and second, cells with the HPA-1b/
1b genotype showed a more robust reorganization of
actin. The application of cytohalasin D abolished the dif-
ferences in cell adhesion in regard to the HPA-1 genotype.
Although the experimental design significantly differs
compared to our experimental protocol, this report repre-
sents one additional experimental proof that HPA-1 poly-
morphism significantly modulates platelet adhesion and
that this modulation is also dependent upon local hemo-
dynamic conditions.
Conclusion
• Platelet adhesion onto immobilized fibrinogen under
arterial flow conditions is mediated by integrin αIIbβ3.
• This specific interaction between immobilized fibrino-
gen and platelet integrin αIIbβ3 is modulated by the HPA-
1 polymorphism of the β-subunit of integrin αIIbβ3.
• The HPA-1b/1b genotype is associated with an increased
of stable platelet adhesion.
• This increased adhesion of HPA-1b/1b platelets is
already evident within 1 min following the interaction of
platelets with immobilized fibrinogen.
Our data support the contention that genetically deter-
mined variants of platelet integrins αIIbβ3 could play a
role in arterial thrombogenesis and thus confirm the
hypothesis derived from epidemiological studies. How-
ever, the risk attributable to only a single polymorphism
in a complex disease such as stroke or myocardial infarc-
tion is probably low. Thus, a single polymorphism may
have no clinical significance if evaluated independently,
but specific combinations of common polymorphisms
and the combination of related polymorphisms might
play a relevant role in these diseases. In other words, the
thrombotic effect of platelet receptor polymorphisms
(single or combined) might be restricted to a combinationThrombosis Journal 2007, 5:2 http://www.thrombosisjournal.com/content/5/1/2
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with microenvironmental risk factors as demonstrated in
our study. Understanding of the functional roles of plate-
let receptor polymorphism may increase our ability to fur-
ther stratify patients according to their genetically
determined thrombosis risk and may give us the opportu-
nity to design and develop individually based therapeutic
strategies in the prevention of arterial thrombosis.
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